Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy?

All rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on thebmj.com. Although a selection of rapid responses will be included online and in print as readers' letters, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window. Letters are indexed in PubMed.

Having first come across this condition on a student elective in Chile in 1984 when it was one of the commonest reasons for antenatal admission I was fascinated that our management has not really progressed since then and uncertainties remain. I was therefore pleased to see that a high quality randomised trial is being conducted.
For me as a GP an additional concern following a delivery complicated by ICP is the question regarding the safety of the combined oral contraceptive pill and the risk of developing cholestasis clinically or sub clinically. Currently it is considered a FSRH UKMEC 2. A useful follow on for this cohort of patients would be to identify contraceptive choices and outcomes.